ZOLL Highlights Advanced CPR Technologies, Data Integration with X Series

March 6, 2013 —CHELMSFORD, MASS.—ZOLL ® Medical Corporation, a manufacturer of medical devices and related software solutions, will showcase the company’s portfolio of integrated CPR technologies and demonstrate data integration with the ZOLL...


ZOLL Breakfast and Learn: “Changing Your Organization’s Resuscitation Mindset”
In the not-so-distant past, many professional rescuers viewed CPR as an almost futile effort. No more. Thanks to evidence-based changes in CPR delivery and new technology, we know the power of really good CPR.  Two experienced EMS providers and instructors from the Mesa Fire/Medical Department, EMS Captain John Tobin and Engineer, EMT Scott Crawford, have seen it firsthand. They will share how training and incorporating ZOLL’s CPR Dashboard into the equation have dramatically improved survival rates in Mesa. Learn methods you can take back to your own organization to make this culture shift. The session will be held Friday, March 8 at 8:30 a.m. Convention Center Room #102AM.

About ZOLL Medical Corporation
ZOLL Medical Corporation, an Asahi Kasei Group company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and critical care. For more information, visit www.zoll.com.

About Asahi Kasei
The Asahi Kasei Group is a diversified group of companies led by holding company Asahi Kasei Corp., with operations in the chemicals and fibers, homes and construction materials, electronics, and health care business sectors. Its health care operations include devices and systems for critical care, dialysis, therapeutic apheresis, transfusion, and manufacture of biotherapeutics, as well as pharmaceuticals, diagnostic reagents, and nutritional products. With more than 25,000 employees around the world, the Asahi Kasei Group serves customers in more than 100 countries. For more information, visit www.asahi-kasei.co.jp/asahi/en/.

 1Wik L, et al. The impact of CPR duration on survival to discharge between integrated AutoPulse-CPR and manual–CPR during out-of-hospital cardiac arrest of presumed cardiac origin. Resuscitation. 2012;83:e17